Hematopoietic Stem Cell Transplantation: Recent Advances

Affiliations

Editorial

Giuseppe Milone et al. J Clin Med. 2025.

. 2025 May 13;14(10):3379.

doi: 10.3390/jcm14103379.

¹ Program for Hematopoietic Stem Cells Transplantation, Azienda Ospedaliera Universitaria Policlinico di Catania, 95100 Catania, Italy.

Abstract

Hematopoietic progenitor cell transplantation was the first form of cell therapy to be developed [...].

The authors declare no conflicts of interest.

1. Thomas E.D., Buckner C.D., Cheever M.A., Clift R.A., Einstein A.B., Fefer A., Neiman P.E., Sanders J., Storb R., Weiden P.L. Marrow transplantation for leukemia and aplastic anemia. Transplant. Proc. 1976;8:603–605. doi: 10.1007/BF01665082. - DOI - PubMed
1. Weiden P.L., Flournoy N., Thomas E.D., Prentice R., Fefer A., Buckner C.D., Storb R. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 1979;300:1068–1073. doi: 10.1056/NEJM197905103001902. - DOI - PubMed
1. Döhner H., Wei A.H., Appelbaum F.R., Craddock C., DiNardo C.D., Dombret H., Ebert B.L., Fenaux P., Godley L.A., Hasserjian R.P., et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–1377. doi: 10.1182/blood.2022016867. - DOI - PubMed
1. Loke J., Buka R., Craddock C. Allogeneic stem cell transplantation for acute myeloid leukemia: Who, when, and how? Front. Immunol. 2021;12:659595. doi: 10.3389/fimmu.2021.659595. - DOI - PMC - PubMed
1. Gooley T.A., Chien J.W., Pergam S.A., Hingorani S., Sorror M.L., Boeckh M., Martin P.J., Sandmaier B.M., Marr K.A., Appelbaum F.R., et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 2010;363:2091–2101. doi: 10.1056/NEJMoa1004383. - DOI - PMC - PubMed